Belpointe Asset Management LLC

Position in INCY — Incyte Corp

CIK 1721242 RENO, NV

Position in INCY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$2,881,951

+$2,623,874 QoQ

Shares Held

25,423

+827.2% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#286

of 854 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Belpointe Asset Management LLC holds $13,833,173 across 13 Biotechnology names. INCY ranks #1 (20.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp This page	25,423	$2,881,951
2	TGTX	Tg Therapeutics, Inc.	50,719	$2,786,501
3	MRNA	Moderna, Inc.	32,598	$2,282,837
4	VRTX	Vertex Pharmaceuticals Inc / Ma	3,741	$1,858,266
5	REGN	Regeneron Pharmaceuticals, Inc.	2,371	$1,478,413
6	HALO	Halozyme Therapeutics, Inc.	15,682	$1,227,430
7	CADL	Candel Therapeutics, Inc.	52,778	$543,613
8	RPRX	Royalty Pharma plc	5,485	$307,543

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,881,951	25,423	+827.2%	Shares	Other	2026-07-31
2026-03-31	$258,077	2,742	-14.3%	Shares	Sole	2026-04-28
2025-12-31	$316,064	3,200	-25.9%	Shares	Sole	2026-01-27
2025-09-30	$366,294	4,319	+35.4%	Shares	Sole	2025-11-03
2025-06-30	$217,170	3,189	-12.1%	Shares	Sole	2025-07-22
2024-12-31	$250,516	3,627	-0.5%	Shares	Sole	2025-02-13
2024-09-30	$241,066	3,647	-0.5%	Shares	Sole	2024-11-13
2024-06-30	$222,293	3,667	+2.0%	Shares	Sole	2024-08-02
2024-03-31	$204,807	3,595	+6.0%	Shares	Sole	2024-05-08
2023-12-31	$212,858	3,390	+47.0%	Shares	Sole	2024-02-13
2023-03-31	$166,654	2,306	+5968.4%	Shares	Sole	2023-05-15
2022-12-31	$3,052	38	-99.2%	Shares	Sole	2023-02-08
2020-03-31	$340,885	4,655	—	Shares	Sole	2020-07-20
No filing history on record for this holder in this stock.